Sarah DeFeo

Chief Tech/Sci/R&D Officer at Ovarian Cancer Research Fund, Inc.

Consumer Services

Finance

Profile

Sarah DeFeo is currently the Vice President-Scientific Affairs & Programs at Ovarian Cancer Research Fund, Inc. She previously worked as a Principal at Icahn School of Medicine at Mount Sinai.
Ms. DeFeo holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Vassar College.

Sarah DeFeo active positions

Companies	Position	Start
Ovarian Cancer Research Fund, Inc. Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY.	Chief Tech/Sci/R&D Officer	2010-08-09

All active positions of Sarah DeFeo

Former positions of Sarah DeFeo

Companies	Position	End
Icahn School of Medicine at Mount Sinai	Corporate Officer/Principal	-

See the detail of Sarah DeFeo's experience

Training of Sarah DeFeo

Vassar College	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah DeFeo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Ovarian Cancer Research Fund, Inc. Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY.	Finance